IVA Inventiva S.A.

NASDAQ
$3.46

Inventiva S.A. (IVA) is confirmed to report earnings on September 28, 2026, before the market open. The consensus earnings estimate is a loss of $0.16 per share.

Earnings Date
3rd Quarter, Sep 2026
Sep 28
Monday · Before Open
Earnings Whisper
-
vs ($0.16)
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP -

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Inventiva S.A.

Inventiva is a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of NASH, MPS and other diseases with significant unmet medical need.

Sector

Healthcare

Industry

Biotechnology

Charts powered in part by Lightweight Charts™ by TradingView.